Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations
  • D&H Cancer Research Center Margate, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

NCT06623422

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0181) Gilbert, Arizona, United States
  • The University of Arizona Cancer Center - North Campus ( Site 0163) Tucson, Arizona, United States
  • Providence St. Jude Medical Center ( Site 0106) Fullerton, California, United States
  • VA Long Beach Healthcare System ( Site 0199) Long Beach, California, United States
View all 238 locations
View Trial Details
Recruiting

Intratumoral N17350 in Advanced Solid Tumors

NCT07339176

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Triple-Negative, +33 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

NCT06745908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare - Orange Coast Medical Center Fountain Valley, California, United States
  • OPN Healthcare INC Glendale, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT07155174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Yale University School of Medicine /ID# 278181 New Haven, Connecticut, United States
  • Ocala Oncology Center /ID# 278269 Ocala, Florida, United States
  • Moffitt Cancer Center /ID# 277573 Tampa, Florida, United States
  • Fort Wayne Medical Oncology And Hematology /ID# 277336 Fort Wayne, Indiana, United States
View all 61 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

NCT07513376

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Smilow Cancer Center at Yale-New Haven ( Site 3253) New Haven, Connecticut, United States
  • Billings Clinic ( Site 3255) Billings, Montana, United States
  • NHO Revive Research Institute, LLC ( Site 3218) Lincoln, Nebraska, United States
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 3207) Reno, Nevada, United States
View all 42 locations
View Trial Details

Related conditions